ResMed reported $280.19M in Operating Profit for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Ansell ANN:AU USD 93M 29.9M
Cochlear COH:AU AUD 185.7M 20.1M
CSL CSL:AU USD 2.13B 1.42B
Estia Health EHE:AU AUD -9636000 30.28M
Fisher & Paykel Healthcare FPH:AU NZD 126.7M 76.5M
Healius Ltd HLS:AU AUD -13200000 118.9M
Integral Diagnostics Ltd IDX:AU AUD 27.01M 14.07M
Mayne Pharma MYX:AU AUD -166537000 12.42M
Nanosonics Ltd NAN:AU AUD 10.65M 12.22M
Polynovo Ltd PNV:AU AUD -3508410 837K
Ramsay Health Care RHC:AU AUD 511M 95M
Regis Healthcare REG:AU AUD -2976000 18.29M
ResMed RMD:AU USD 280.19M 24.8M
Sigma Healthcare Ltd SIG:AU AUD 5.4M 7.46M
Sonic Healthcare SHL:AU AUD 578.99M 369.26M
Telix Pharmaceuticals Ltd TLX:AU AUD -24543000 42.84M